In this series, we explore the impact of data from the National Genomic Research Library and highlight opportunities for ...

You can use the form below to sign up for email alerts about new positions as they open. Fields marked with an asterisk (*) are required. Genomics England is a global leader in enabling genomic ...

All projects undertaken using data in the National Genomic Research Library are publicly listed in the Genomics England Research Registry. These projects exemplify the breadth of research and its ...

In this episode of our explainer podcasts, we’ve asked Emma McCargow, Programme Lead for the cancer programme at Genomics England, to explain in less than 10 minutes, the difference between long-read ...

A boy born with a rare form of eye cancer, usually diagnosed in very young children, is one of numerous babies born with rare conditions who are receiving earlier diagnoses and faster, lifechanging ...

British tech company Lifebit and Amazon Web Services to support a dedicated environment for researchers working on COVID-19 vaccines and treatments Genomics England (GEL) has today launched a ...

Genomics England sets out early thinking on how a research pilot will gather evidence on the benefits, challenges and practicalities of offering whole genome sequencing to all newborns Research will ...

We're going back to basics today, and in this explainer podcast, we’ve asked Greg Elgar, Director of Sequencing R&D here at Genomics England, to clarify in less than 10 minutes, exactly what is a ...

In this series, ‘Genomics 101’, we go back to basics and explore some of the most important topics in genomics. In this blog, we explain what is meant by RNA, how it is different from DNA, and why our ...

Hundreds of babies have begun to be tested for over 200 rare genetic conditions as part of a world-leading study in NHS hospitals that aims to screen up to 100,000 newborns in England. The Generation ...

One hundred thousand whole genomes have now been sequenced through the NHS Genomic Medicine Service (NHS GMS) – supported by Genomics England and Illumina - which has led to new diagnoses, more ...